Research Scientist
Gilead Sciences Inc
Michelle D'Antoni, PhD, is a research scientist in the Clinical Virology group at Gilead Sciences Inc. As a clinical virologist, Michelle D'Antoni's therapeutic area of study is HIV, with a focus on Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide; B/F/TAF) clinical trial programs. Michelle is presenting author of poster 633 titled "Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Efficacy in Participants with Pre-Existing Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials".
Disclosure: Gilead Sciences (Individual(s) Involved: Self): Employee, Shareholder
